Clinical Trial

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-17
Trial Details
NCT Number NCT07698886
Lead Sponsor KTH Biopharma
Conditions HPV (Human Papillomavirus)-Associated, Genital Warts
Enrollment 70 participants
Start Date 2026-07-16
Primary Completion 2027-08-15 (estimated)
Study Completion 2027-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-06